Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint=true, destructiveHint=false and openWorldHint=false, so the safety profile is covered. Beyond that the description only offers 'RETURNS: 多组学关联结果', which gives no real information about output structure, statistical method, or what happens when only some layers are supplied. Almost nothing is added beyond structured fields.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Is the description appropriately sized, front-loaded, and free of redundancy?

The pipe-delimited metadata format keeps it short and the USE WHEN clause is front-loaded, but the bilingual title duplicates the tool title field and the ALIASES segment consumes space without helping tool selection. Signal-to-noise is mediocre rather than tight.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

All four parameters are optional, there is no output schema, and the description never states minimum input requirements or what the association result contains. For a multi-layer analysis tool that can be invoked with zero arguments, that omission is the main completeness gap, though the fully documented schema mitigates it.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema description coverage is 100%, so the baseline is 3: each of mrna, protein, metabolite and pathway_map is documented in the schema. The description adds no meaning beyond those field labels — notably it does not explain accepted 'pathway_map' modes or whether at least two layers are required.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Does the description clearly state what the tool does and how it differs from similar tools?

The description names the specific operation and domain: integrating mRNA/protein/metabolite layers to find cross-layer associations, which is more than a restatement of the name. It does not, however, distinguish itself from adjacent siblings such as metabolite_pathway, go_kegg_enrichment, ppi_network or protein_enrichment, so an agent must infer the boundary itself.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Does the description explain when to use this tool, when not to, or what alternatives exist?

The 'USE WHEN' clause gives a usable trigger condition (multiple omics layers plus a cross-layer association goal), but it essentially paraphrases the purpose and offers no when-not guidance, no prerequisites, and no named alternative tools. The long alias list ('多组学, 整合分析, cross-omics') is matching noise rather than usage guidance.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.